A carregar...
Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
Therapy for acute myeloid leukemia (AML) involves intense cytotoxic treatment and yet approximately 70% of AML are refractory to initial therapy or eventually relapse. This is at least partially driven by the chemo-resistant nature of the leukemic stem cells (LSCs) that sustain the disease, and ther...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889502/ https://ncbi.nlm.nih.gov/pubmed/29921955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0087-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|